[go: up one dir, main page]

Karamipour et al., 2015 - Google Patents

Fabrication and spectroscopic studies of folic acid-conjugated Fe3O4@ Au core–shell for targeted drug delivery application

Karamipour et al., 2015

Document ID
5804416062239213647
Author
Karamipour S
Sadjadi M
Farhadyar N
Publication year
Publication venue
Spectrochimica acta Part A: Molecular and biomolecular spectroscopy

External Links

Snippet

Gold coated magnetite core shell is a kind of nanoparticle that include magnetic iron oxide core with a thin layer nanogold. Fe 3 O 4–gold core–shell nanostructure can be used in biomedical applications such as magnetic bioseparation, bioimaging, targeting drug delivery …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANO-TECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES
    • B82Y30/00—Nano-technology for materials or surface science, e.g. nano-composites

Similar Documents

Publication Publication Date Title
Karamipour et al. Fabrication and spectroscopic studies of folic acid-conjugated Fe3O4@ Au core–shell for targeted drug delivery application
Ghaffari et al. Functionalization of ZnO nanoparticles by 3-mercaptopropionic acid for aqueous curcumin delivery: Synthesis, characterization, and anticancer assessment
Soufi et al. Eco-friendly and sustainable synthesis of biocompatible nanomaterials for diagnostic imaging: current challenges and future perspectives
Wu et al. Designed synthesis and surface engineering strategies of magnetic iron oxide nanoparticles for biomedical applications
Mirza et al. Preparation and characterization of doxorubicin functionalized gold nanoparticles
Sheng et al. Nanoparticles for molecular imaging
Han et al. Potential use of SERS-assisted theranostic strategy based on Fe3O4/Au cluster/shell nanocomposites for bio-detection, MRI, and magnetic hyperthermia
Ke et al. A specific tumor-targeting magnetofluorescent nanoprobe for dual-modality molecular imaging
Kale et al. Magnetite/CdTe magneticfluorescent composite nanosystem for magnetic separation and bio-imaging
Nosrati et al. Biocompatibility and anticancer activity of L-phenyl alanine-coated iron oxide magnetic nanoparticles as potential chrysin delivery system
Saepudin et al. The influence of carboxylate moieties for efficient loading and pH-controlled release of doxorubicin in Fe3O4 magnetic nanoparticles
Rahimi et al. Highly branched amine-functionalized p-sulfonatocalix [4] arene decorated with human plasma proteins as a smart, targeted, and stealthy nano-vehicle for the combination chemotherapy of MCF7 cells
Maboudi et al. Theranostic magnetite cluster@ silica@ albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents
Shahabadi et al. Functionalization of Fe3O4@ SiO2 magnetic nanoparticles with nicotinamide and in vitro DNA interaction
Babayevska et al. Functionalized multimodal ZnO@ Gd2O3 nanosystems to use as perspective contrast agent for MRI
Nasiri et al. In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells
US9023370B2 (en) Conjugates comprising nanoparticles coated with platinum containing compounds
Kumar et al. Surface coating and functionalization of metal and metal oxide nanoparticles for biomedical applications
Ravichandran et al. Biofunctionalized MnFe2O4@ Au core–shell nanoparticles for pH-responsive drug delivery and hyperthermal agent for cancer therapy
Mohajer et al. New advances on Au–magnetic organic hybrid core–shells in MRI, CT imaging, and drug delivery
Fatematossadat et al. Fe@(Au/Ag) n (n= 1, 12, 54) core-shell nanoparticles as effective drug delivery vehicles for anti-cancer drugs: The computational study
Chow Synthesis and applications of functionalized nanoparticles in biomedicine and radiotherapy
Fahmi et al. Naproxen release from carbon dot coated magnetite nanohybrid as versatile theranostics for HeLa cancer cells
Liu et al. Monosized core–shell Fe3O4 (Fe)/Au multifunctional nanocrystals
Shelar et al. Electrostatically bound lanreotide peptide-gold nanoparticle conjugates for enhanced uptake in SSTR2-positive cancer cells